CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Thanks to their second quarter financial reports these medical device companies are experiencing growth in their stocks.
By Jocelyn Aspa
The Investing News Network recently had the opportunity to speak with Nick Dinsmoor, vice president, strategic marketing, of VirtualArmour about the company’s new managed service contracts and the cybersecurity industry as a whole.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
A new study evaluating the clinical trials medical devices go through as part of their redesigns or updates found these can often rely on “inadequate or potentially biased data.”
ConforMIS acquired machining and polishing assets from Broad Peak Manufacturing in an attempt to reduce the costs of services it has used for its products since 2014.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
As medical devices get technological advancements placing them into networks, the danger of threats to these crucial devices is growing as well. A new piece of legislation in the US Senate seeks to add mandated tests and better protections for remote access points.
Medigus announced a distribution agreement in Switzerland and Liechtenstein with ADMEDICS AG medical device distributor.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.